1- (1- (2,3,3alpha,4,5,6- hexahydro- 1H- phenalen- 1- yl)piperidin- 4- yl)indolin- 2- one
a ligand of both ociceptin/orphanin FQ peptide receptor and mu-opioid receptor
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Pain (Aches)
07/01/2013
- " Antinociceptive effects of bifunctional NOP/MOP ligands BU08028 [(2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol] and SR16435 [1-(1-(2,3,3α,4,5,6-hexahydro-1H-phenalen-1-yl)piperidin-4-yl)-indolin-2-one] were pharmacologically compared with the putative bifunctional ligand buprenorphine, selective NOP agonist SCH221510 [3-endo-8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol] and selective MOP agonist morphine in neuropathic and inflammatory pain models. "
|
2. | Inflammation (Inflammations)
|
3. | Hyperalgesia
|
|
Related Drugs and Biologics